RA Capital Healthcare Fund LP

Director

RA Capital Healthcare Fund LP (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in TYRA. The largest single filing was $58.4M of FULC (4,175,139 sh across 3 lots, as filed), executed Dec 8 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$58.4M

shares × price, as filed

Last traded

Dec 8 2025

Filed Dec 10 2025

Median ADV $9.2M across their filed names

Open performance→

Volume by month

Buys $47.1M Sells $58.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

TYRA TYRA TYRA · 2 buys · 0 sells 2 filings FULC

Fulcrum Therapeutics, Inc. FULC · 0 buys · 1 sell 1 filing JANX JANX JANX · 1 buy · 0 sells 1 filing

Recent filings

FULCSALE Fulcrum Therapeutics, Inc. View filing → $58.4M
4,175,139 sh across 3 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET TYRAPURCHASE Tyra Biosciences, Inc. View filing → $1.9M
186,850 sh × $10.19
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET JANXPURCHASE Janux Therapeutics, Inc. View filing → $25.3M
824,041 sh across 4 lots
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET TYRAPURCHASE Tyra Biosciences, Inc. View filing → $19.8M
1,220,681 sh × $16.25
Exec Nov 8 2024
Filed Nov 13 2024 · 5:30 PM ET